Project Grant HT94252410651
Award Date
9/1/24
Completion Date
8/31/28
Dollars Obligated
$1.3M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Cleveland, OH 44195, USA
Similar Awards
The Defense Health Agency awarded The Cleveland Clinic Foundation, a non-profit academic medical center, a $893,768 Project Grant under the Military Medical Research and Development (CFDA 12.420) program. The two-year grant, effective from September 1, 2023 to August 31, 2025, supports the development of multimodal AI-based solutions to enhance renal cancer patient care. As a leader in medical research, education, and healthcare delivery, The Cleveland Clinic Foundation will leverage its...
The Defense Health Agency awarded a $1,023,225 Project Grant under the Military Medical Research and Development program (CFDA# 12.420) to The Cleveland Clinic Foundation. The grant funds research to investigate the therapeutic relevance of targeting the anti-apoptotic Bcl-xL protein in kidney cancer. A sub-award to Harvard T.H. Chan School of Public Health will perform BH3 profiling to compare apoptotic responses in renal cell carcinomas under varied conditions, including treatment with BH3...
This Project Grant award of $471,000.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The funding supports research by The Cleveland Clinic Foundation to develop next-generation prostate cancer therapeutics by exploiting the allosteric regulation of the androgen receptor. The award period is from September 1, 2023 to August 31, 2025. As a prime recipient of federal grants, The Cleveland Clinic Foundation has a history of...
This $480,000 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) supports research by The Cleveland Clinic Foundation, a non-profit academic medical center, to study the role of the citron kinase protein in castration-resistant prostate cancer. The 2-year project, beginning on May 1, 2024, seeks to gain mechanistic insights that could lead to new therapeutic opportunities for this challenging form of prostate...
This federal Project Grant award for $704,000.00, awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research by the Sloan-Kettering Institute for Cancer Research in New York, NY. The research aims to investigate the role of the NF-I/A transcription factor in regulating fatty acid metabolism in kidney cancer. This multi-year project will run from September 1, 2024 to August 31, 2028. As the prime grantee, the Sloan-Kettering...
This Project Grant award in the amount of $559,874 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Cleveland Clinic Foundation. The award will fund research targeting genomic drivers of Hurthle cell thyroid cancer through the use of mTOR and eIF2 inhibition. The performance period for this grant is from September 30, 2024 to September 29, 2026. As a leading academic medical center and research institution, The Cleveland...
The federal Project Grant award, with ID HT94252510141, is from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The $240,000 grant, awarded on March 15, 2025, supports research by The Cleveland Clinic Foundation to explore the causality and mechanism of androgen receptor (AR) extrachromosomal DNA (ecdna) in the progression of malignant prostate cancer. The award has a performance period through March 14, 2027. As a prominent non-profit...
The Cleveland Clinic Foundation will investigate the importance of the gut microbial endocrine organ in kidney cancer development and therapeutic response under a $591,702 Project Grant from the Department of the Army Medical Command. The grant is part of the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform military and public health care through innovative medical solutions for battlefield wounds and...
This Project Grant award from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420) provides $1,200,000.00 to The Cleveland Clinic Foundation to support research aimed at disrupting the CX26-FAK-NANOG complex to attenuate cancer stem cell self-renewal and triple-negative breast cancer progression. The award period runs from May 1, 2025 to April 30, 2028. The Cleveland Clinic Foundation, a prominent nonprofit academic medical center, will...
The U.S. Defense Health Agency awarded a $559,992 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to The Cleveland Clinic Foundation. The grant supports the "Bench-to-Bedside Development of Superior CAR T-Cell Therapy for Leukemia" research project, which aims to transform healthcare for military service members, veterans, and the public through innovative biomedical research. The project will run from September 30, 2025 to September 29, 2028,...